Translational Bridge Award
Invests in lupus translational projects through the Translational Bridge Award to move discoveries toward clinical testing.
The Translational Bridge Award is a grant program of the Lupus Research Alliance (LRA) designed to accelerate the movement of promising lupus discoveries from post-discovery research into pre-commercial development and clinical evaluation. The LRA, a New York-based 501(c)(3) nonprofit (Federal Tax ID #58-2492929), has issued more than $284 million across 675+ grants, with its 2024–2028 Research Ro…
Technologies, therapies, interventions, and diagnostics for lupus that bridge post-discovery and pre-commercial development, with a clear path to viable clinical products that improve diagnosis or standard of care.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline